Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,007 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The tissue-resident marker CD103 on peripheral blood T cells predicts responses to anti-PD-1 therapy in gastric cancer.
Nose Y, Saito T, Yamamoto K, Yamashita K, Tanaka K, Yamamoto K, Makino T, Takahashi T, Kawashima A, Haruna M, Hirata M, Ueyama A, Iwahori K, Satoh T, Kurokawa Y, Eguchi H, Doki Y, Wada H. Nose Y, et al. Cancer Immunol Immunother. 2023 Jan;72(1):169-181. doi: 10.1007/s00262-022-03240-2. Epub 2022 Jul 1. Cancer Immunol Immunother. 2023. PMID: 35776160 Free PMC article.
ASO Author Reflections: Can Perioperative Ghrelin Administration Inhibit Postoperative Muscle Mass Loss in Esophageal Cancer Patients?
Nose Y, Yamashita K, Takeoka T, Momose K, Saito T, Tanaka K, Yamamoto K, Makino T, Takahashi T, Kurokawa Y, Yamasaki M, Shiraishi O, Miyata H, Yasuda T, Yano M, Eguchi H, Doki Y. Nose Y, et al. Ann Surg Oncol. 2022 Jun;29(6):3613-3614. doi: 10.1245/s10434-022-11437-z. Epub 2022 Feb 15. Ann Surg Oncol. 2022. PMID: 35166955 No abstract available.
Perioperative Ghrelin Administration Attenuates Postoperative Skeletal Muscle Loss in Patients Undergoing Esophagectomy for Esophageal Cancer: Secondary Analysis of a Randomized Controlled Trial.
Nose Y, Yamashita K, Takeoka T, Momose K, Saito T, Tanaka K, Yamamoto K, Makino T, Takahashi T, Kurokawa Y, Yamasaki M, Shiraishi O, Miyata H, Yasuda T, Yano M, Eguchi H, Doki Y. Nose Y, et al. Ann Surg Oncol. 2022 Jun;29(6):3604-3612. doi: 10.1245/s10434-022-11436-0. Epub 2022 Feb 20. Ann Surg Oncol. 2022. PMID: 35187621 Clinical Trial.
A novel, simple, and dedicated device for endoscopic mucosal defect closure.
Nose Y, Takizawa K, Shiotsuki K, Yamaguchi T, Agatsuma M, Nitta S, Yamashita K, Saito T, Tanaka K, Yamamoto K, Makino T, Takahashi T, Kurokawa Y, Eguchi H, Doki Y, Nakajima K. Nose Y, et al. DEN Open. 2022 Mar 9;2(1):e98. doi: 10.1002/deo2.98. eCollection 2022 Apr. DEN Open. 2022. PMID: 35873505 Free PMC article.
Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancer.
Kawada J, Saito T, Kurokawa Y, Kawabata R, Takeno A, Takeoka T, Nose Y, Wada H, Eguchi H, Doki Y; Osaka University Clinical Research Group for Gastroenterological Study. Kawada J, et al. Among authors: nose y. Ann Gastroenterol Surg. 2023 Nov 20;8(2):243-250. doi: 10.1002/ags3.12757. eCollection 2024 Mar. Ann Gastroenterol Surg. 2023. PMID: 38455491 Free PMC article.
[A Case of Gastric Cancer Associated with Membranous Glomerulonephritis].
Nose Y, Takeno A, Tamura S, Taniguchi H, Ishida T, Sato Y, Morimoto Y, Kusama H, Hashimoto T, Matsushita K, Kimura K, Kagawa Y, Sakisaka H, Katsura Y, Ohmura Y, Takeda Y, Kato T. Nose Y, et al. Gan To Kagaku Ryoho. 2015 Nov;42(12):1977-9. Gan To Kagaku Ryoho. 2015. PMID: 26805236 Review. Japanese.
1,007 results